Vascular access: indications and implications for patient care

Abstract

This overview of the vascular access devices available for adult patients explains how careful selection and management of the device can minimise the complications associated with infusion therapy.

The handling of peripheral venous catheters – from non‐compliance to evidence‐based needs

“…Peripheral venous catheters (PVCs) are one of the most frequently used medical devices in the world (Gabriel et al. 2005).…”

“…Peripheral venous catheters (PVCs) are one of the most frequently used medical devices in the world (Gabriel et al 2005). Intravenous therapy with drugs, nutrients and blood components is indispensable in today's health care, and approximately five million PVCs are used every year in Sweden (SBU 2005).…”

Central venous haemodialysis catheter insertion. Is there any difference to the insertion of central venous catheters for other use?

“…Late complications appear to be less frequent for dialysis catheters and this may be attributed to their highly specialized use. and cooperation is necessary for successful CVC insertion [3]. Although more than 5 million central venous catheters are placed each year in the USA [4], vascular thrombosis, catheter-related infections and mechanical complications still impose a substantial burden on patients, and yet could be prevented [5].…”

“…The femoral vein is easy to access and is the preferred site for patients with coagulation related diseases. However, the femoral vein carries the highest risk of infection and thrombosis [3]. In our study, the subclavian vein was selected in most cases.…”

Peripheral intravenous catheter use in Europe: towards the use of safety devices

“…T HE intravenous catheter (IVC) is one of the most ubiquitous medical devices in the world. Approximately four out of five hospitalised patients have an IVC inserted at some point during their stay (1). We have already described the history of this remarkable device (2) and have provided guidelines as to best practice regarding its use in the individual patient (3).…”